Associations - HER-2 S310F

BIOMARKER:

HER-2 S310F

Entrez ID:

Related biomarkers:

‹

›

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

VERI is free for non-commercial use, no login needed.

Content on this site is for research purposes only and is not intended to be a substitute for medical advice.

For commercial access, including additional premium features, please contact us.

By using VERI, you are agreeing to our

and

HER-2 S310F HER-2 S310F	Lung Adenocarcinoma LUAD	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4
HER-2 S310F HER-2 S310F	Colorectal Cancer CRC	afatinib Sensitive: C4 – Case Studies afatinib Sensitive : C4
HER-2 S310F HER-2 S310F	HER2 Negative Breast Cancer HER2 Negative Breast Cancer	lapatinib Sensitive: C4 – Case Studies lapatinib Sensitive : C4
HER-2 S310F HER-2 S310F	Solid Tumor Solid Tumor	BDTX-189 Sensitive: D – Preclinical BDTX-189 Sensitive : D
HER-2 S310F HER-2 S310F	Non Small Cell Lung Cancer NSCLC	ado-trastuzumab emtansine Sensitive: D – Preclinical ado-trastuzumab emtansine Sensitive : D
HER-2 S310F HER-2 S310F	Colorectal Cancer CRC	cetuximab Resistant: D – Preclinical cetuximab Resistant : D
HER-2 S310F HER-2 S310F	Colorectal Cancer CRC	panitumumab Resistant: D – Preclinical panitumumab Resistant : D